News

Keya medical's plaque analysis and FFR-CT reports generated from a single CT scan.

The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

Pi-Cardia ShortCut TAVR device

The FDA-cleared ShortCut leaflet modification device has been linked to positive real-world outcomes.

These "forward-thinking organizations" have all committed to participating in multiple data registries and quality improvement programs. Did your facility make the cut? 

Roderick Tung explains cardio-neuro ablation therapy for recurrent vasovagal syncope

The procedure is designed to help patients who experience frequent fainting episodes that impair their quality of life.

Medicare Advantage

"These high costs could pose barriers to care for such plans’ beneficiaries,” researchers wrote July 1 in the American Journal of Roentgenology

cybersecurity cyberattack hack hackers lock protection

The feds cautioned that exploitation of these vulnerabilities could allow attackers to write files, access unauthorized information, or crash client servers. 

Stravitz Sanyal Institute for Liver Disease and Metabolic Health at VCU

The Stravitz Sanyal Institute for Liver Disease and Metabolic Health at VCU seeks to develop new treatments that could help the millions of individuals impacted by these ailments. 

surgeon

With Election Day only four months away, healthcare is again emerging as a major source of idealistic campaign promises. Many of these are driven by widespread public angst. What sorts of changes can U.S. healthcare stakeholders realistically expect once the results are in? 

heart drugs with stethoscope

Nearly 700 bottles of a popular ACE inhibitor are being recalled after it failed an Organic Impurities Test. The drug was manufactured in India and then distributed by New Jersey-based Rising Pharma Holdings.

Cardiac amyloidosis on nuclear imaging of the heart using 11C-PiB PET/CT. Image courtesy of RSNA

Cardiac amyloidosis continues to get more and more attention at cardiology meetings. At Heart Failure 2026 in Spain, it was the topic of multiple studies, including one on the benefits of acoramidis.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Performing TAVR on a patient with bicuspid AS can be challenging. Transcatheter aortic root tricuspidization may represent a new treatment strategy for these patients, according to a new first-in-human trial.

chest pain lung pulmonary embolism

In new Neiman Health Policy Institute research, scientists explored the use of artificial intelligence to aid in diagnosing PE on CTPA, with “AI-informed radiologists" scoring high marks. 

Around the web

The company now has multiple FDA-cleared algorithms for evaluating CCTA results.

The FDA-cleared ShortCut leaflet modification device has been linked to positive real-world outcomes.

These "forward-thinking organizations" have all committed to participating in multiple data registries and quality improvement programs. Did your facility make the cut?